Tarsus Pharmaceuticals Inc. (TARS) Social Stream
Tarsus Pharmaceuticals Inc (TARS) Price Targets From Analysts
Use the tables below to see what analysts covering Tarsus Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 29 weeks, TARS's average price target has gone up $12.31.
Over the past 14 months, TARS's average upside potential has been 68.36%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TARS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Tarsus Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 510.1% of all US stocks.
- Tarsus Pharmaceuticals Inc's average analyst price target is higher than 545.69% of stocks in the small market cap category.
- Tarsus Pharmaceuticals Inc's number of analysts covering the stock is higher than 467.64% of stocks in the small market cap category.
- TARS has a less variance in analysts' estimates than -283.81% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ORIC, KDNY and KNTE are the three stocks most similar to Tarsus Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is TARS a Buy, Hold or Sell? See the POWR Ratings now!